Skip to content
Clinical Trials – home
CroatiaBack to Croatia

Clinical trials in Varazdin – page 4

44 clinical trials in Varazdin, Croatia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Varazdin at a glance
44
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

44 trials in Varazdin

Open in trial search

Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG

Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Cilastatin
  • Sponsor:Spero Therapeutics Inc.

Study on AVP-786 for Treating Agitation in Alzheimer's Dementia Patients

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Quinidine Sulfate
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Colitis ulcerative

Not recruiting

Long-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years
  • Substances:Charcoal, Activated
  • Sponsor:Novartis Pharma AG

Multiple sclerosis

Not recruiting

Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Varazdin

What the registry says about research in the country

01 Neurological Disorders

Extensive research focusing on Multiple Sclerosis treatments, including studies of novel therapies and comparative effectiveness of existing medications. Multiple trials are evaluating treatments for both relapsing-remitting and primary progressive forms of MS.

  • Relapsing Multiple Sclerosis
  • Primary Progressive MS
  • Long-term Treatment Safety

Several innovative compounds being tested include fenebrutinib, ocrelizumab, and ublituximab for enhanced disease management.

02 Cardiovascular Research

Comprehensive studies addressing various cardiovascular conditions, from heart failure to prevention of major cardiovascular events. Research includes innovative treatments for atrial fibrillation and stroke prevention.

  • Heart Failure Management
  • Atherosclerotic Disease Prevention
  • Stroke Prevention

Trials evaluating new compounds like milvexian and finerenone for improved cardiovascular outcomes.

03 Respiratory Medicine

Clinical research examining new treatments for moderate to severe asthma, with a focus on improving control in patients with persistent symptoms. Studies evaluating novel therapeutic approaches for better disease management.

  • Uncontrolled Asthma
  • Novel Therapeutic Compounds
  • Symptom Management

Investigation of new compounds like atuliflapon for enhanced asthma control.

04 Oncology Studies

Innovative research in breast cancer treatment, particularly focusing on hormone-receptor-positive cases. Studies evaluating targeted therapies for early-stage breast cancer.

  • ER-Positive Breast Cancer
  • Adjuvant Therapy
  • Endocrine Treatment

Clinical trials examining giredestrant as a potential new treatment option.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.